The ROE as of December 2024 (TTM) for Oncology Pharma Inc. (ONPH) is 0%

According to Oncology Pharma Inc.’s latest financial reports and current stock price. The company's current ROE is 0%. This represents a change of -100.00% compared to the average of -5.79% of the last 4 quarters.

Oncology Pharma Inc. (ONPH) Historical ROE (quarterly & annually)

How has ONPH ROE performed in the past?

The mean historical ROE of Oncology Pharma Inc. over the last ten years is 5.02%. The current 0% ROE has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), ONPH's ROE was at its highest in in the March 2004 quarter at 135.47%. The ROE was at its lowest in in the December 2003 quarter at -52800.00%.

Oncology Pharma Inc. (ONPH) ROE by Quarter and Year

Discovering the peaks and valleys of Oncology Pharma Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Oncology Pharma Inc. (ONPH) Average ROE

How has ONPH ROE performed in the past?

The current ROE of Oncology Pharma Inc. (ONPH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Oncology Pharma Inc. (ONPH) ROE vs. Peers

How is ONPH’s ROE compared to its peers?

Oncology Pharma Inc.’s ROE is less than Regen BioPharma, Inc. (16.75%), less than Propanc Biopharma, Inc. (49.45%), less than Kaleido Biosciences, Inc. (0%), less than RegeneRx Biopharmaceuticals, Inc. (0%), less than Regen BioPharma, Inc. (16.75%), greater than Therapeutic Solutions International, Inc. (-189.05%), less than Alpha Cognition Inc. (666.93%), less than HAVN Life Sciences Inc. (0%), greater than Surrozen, Inc. (-222.75%), greater than Jasper Therapeutics, Inc. (-67.65%), greater than Revelation Biosciences, Inc. (-311.33%), less than Wesana Health Holdings Inc. (255.46%), greater than Living Cell Technologies Limited (-54.06%), less than MultiCell Technologies, Inc. (164.07%), less than Institute of Biomedical Research Corp. (131.12%), less than Health Sciences Group, Inc. (0%), less than Mymetics Corporation (11.73%), greater than Anebulo Pharmaceuticals, Inc. (-184.40%), greater than Aerovate Therapeutics, Inc. (-90.19%), greater than Acrivon Therapeutics, Inc. Common Stock (-47.95%), less than Opthea Limited (398.06%), greater than AN2 Therapeutics, Inc. (-57.63%),

Build a custom stock screener for Oncology Pharma Inc. (ONPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oncology Pharma Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oncology Pharma Inc. (ONPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oncology Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.